CCL20 inhibition for treating inflammation in ankylosing spondylitis.
Rheumatology (Oxford, England)(2023)
摘要
This research validates the critical role of CCL20 in AS and suggests that targeting CCL20 inhibition could serve as a novel therapeutic approach for AS treatment.
更多查看译文
关键词
AS, C-C motif chemokine ligand 20, Th17 cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要